Targeted Screening for Latent TB Infection prior to Biologic Therapy to Improve Patient Safety and Reduce Costs: A Prospective Observational Study

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td align="left">Number of patients</td><td align="center">Ethnicity</td><td align="center">TB risk adjusted ×5 for anti-TNF <br/>effects/100 000</td><td align="center">Risks of <br/>prophylaxis/100 000</td><td align="center">Risk/benefit <br/>conclusion</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td align="left">1</td><td align="center">Black African</td><td align="center">1570</td><td align="center">278</td><td align="center">Prophylaxis</td></tr><tr><td align="left">3</td><td align="center">ISC</td><td align="center">540</td><td align="center">278</td><td align="center">Prophylaxis</td></tr><tr><td align="left">2</td><td align="center">Other</td><td align="center">195</td><td align="center">278</td><td align="center">Observation</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>
							ISC: Indian subcontinent.<br/></td></tr></table>

Risk stratification for patients not born in the UK.

International Scholarly Research Notices

tab5

Table 5

Table 5: Targeted Screening for Latent TB Infection prior to Biologic Therapy to Improve Patient Safety and Reduce Costs: A Prospective Observational Study 

Table 5 | Targeted Screening for Latent TB Infection prior to Biologic Therapy to Improve Patient Safety and Reduce Costs: A Prospective Observational Study 